Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effects

Underwood, Benjamin R. and Fox, Chris (2014) Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effects. Evidence-Based Medicine, 19 (5). p. 181. ISSN 1473-6810

Full text not available from this repository. (Request a copy)
Item Type: Article
Additional Information: Commentary on: Porsteinsson AP, Drye LT, Pollock BG, et al. Effect of citalopram on agitation in Alzheimer disease. The CitAD randomised clinical trial. JAMA 2014;311:682–91.
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: Pure Connector
Date Deposited: 19 Oct 2015 15:00
Last Modified: 28 Oct 2019 14:01
URI: https://ueaeprints.uea.ac.uk/id/eprint/54721
DOI: 10.1136/ebmed-2014-110016

Actions (login required)

View Item View Item